INmune Bio and Quantum Computing partner to apply quantum optimization and AI to advance Alzheimer’s drug research and explore new applications for XPro

INmune Bio (NASDAQ: INMB) and Quantum Computing Inc. (NASDAQ: QUBT) will use QCi’s Dirac-3S quantum optimization machine alongside AI and conventional analytics to identify new potential applications for XPro, INmune Bio’s investigational Alzheimer’s treatment.